# Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis

> **NCT01953354** · PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 16 (actual)

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **BIOLOGICAL:** Trichuris suis ova (TSO)
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01953354
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** MFR's business decision to d/c TSO production -unrelated to any safety concern.
- **Last updated:** 2017-03-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01953354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01953354, "Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01953354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*